Inventor · disambiguated record
Scott D. Edmondson
Also filed as: EDMONDSON SCOTT · EDMONDSON SCOTT D
46 granted patents·14 pending applications·666 citations·filing 2002–2020
97Inventor score
Top patents by PatentIndex Score
60 records- 0198US6699871B2Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2002·Granted Mar 2, 2004·393 cites·26 claims
- 0295US8247415B2Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Aug 21, 2012·40 cites·16 claims
- 0394US8399480B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Mar 19, 2013·36 cites·20 claims
- 0492US8354403B2Pyrrolidine derived beta 3 adrenergic receptor agonistsMERCK SHARP & DOHME·Filed 2010·Granted Jan 15, 2013·15 cites·14 claims
- 0592US7125873B2Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2002·Granted Oct 24, 2006·29 cites·8 claims
- 0691US8653260B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2012·Granted Feb 18, 2014·18 cites·11 claims
- 0791US7157490B2Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2003·Granted Jan 2, 2007·54 cites·23 claims
- 0886US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 0985US8748433B2β3 adrenergic receptor agonistsBERGER RICHARD·Filed 2011·Granted Jun 10, 2014·10 cites·19 claims
- 1084US9809545B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·4 cites·7 claims
- 1183US9868727B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 16, 2018·3 cites·16 claims
- 1283US8168637B2Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetesEDMONDSON SCOTT D·Filed 2010·Granted May 1, 2012·4 cites·2 claims
- 1379US10123995B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Nov 13, 2018·2 cites·14 claims
- 1479US9783530B2Factor Xla inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 10, 2017·2 cites·14 claims
- 1579US7208498B2Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetesMERCK & CO INC·Filed 2003·Granted Apr 24, 2007·13 cites·21 claims
- 1678US8440668B2Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetesEDMONDSON SCOTT D·Filed 2011·Granted May 14, 2013·2 cites·2 claims
- 1778US7884104B2Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2005·Granted Feb 8, 2011·4 cites·15 claims
- 1878US7098239B2Dipeptidyl peptidase inhibitors for the treatment of diabetesMERCK & CO INC·Filed 2002·Granted Aug 29, 2006·12 cites·19 claims
- 1977US7718667B2Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2005·Granted May 18, 2010·2 cites·13 claims
- 2076US10239863B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Mar 26, 2019·1 cites·19 claims
- 2176US10011585B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·2 cites·12 claims
- 2276US9186354B2Pyrrolidine derived β3 adrenergic receptor agonistsMORRIELLO GREGORI J·Filed 2011·Granted Nov 17, 2015·5 cites·6 claims
- 2375US7795265B2Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2007·Granted Sep 14, 2010·3 cites·16 claims
- 2474US10081617B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Sep 25, 2018·2 cites·11 claims
- 2573US2020206221A1Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 2667US9422266B2Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatmentMERCK SHARP & DOHME·Filed 2012·Granted Aug 23, 2016·1 cites·13 claims
- 2767US9018224B2Substituted cyclopropyl compounds useful as GPR119 agonistsMERCK SHARP & DOHME·Filed 2012·Granted Apr 28, 2015·1 cites·25 claims
- 2866US8618144B2Pyrrolidine-derived beta 3 adrenergic receptor agonistsLIN PETER·Filed 2010·Granted Dec 31, 2013·1 cites·15 claims
- 2966US2017348309A1Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 3065US9676723B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jun 13, 2017·1 cites·16 claims
- 3165US9663527B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted May 30, 2017·1 cites·14 claims
- 3264US2013217695A1Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 3362US11161819B2Substituted tetrahydroisoquinoline compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2020·Granted Nov 2, 2021·0 cites·17 claims
- 3462US7332520B2Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2004·Granted Feb 19, 2008·1 cites·17 claims
- 3561US2006270679A1Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesEDMONDSON SCOTT D·Filed 2006·Application pending·0 cites
- 3660US2015359793A1Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 3758US2016257668A1Factor XIa InhibitorsSHAO NING·Filed 2014·Application pending·0 cites
- 3854US2019161448A1Substituted tetrahydroisoquinoline compounds useful as gpr120 agonistsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 3951US8501786B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Aug 6, 2013·0 cites·8 claims
- 4048US2023066268A1Indazole derivatives and methods of use thereof for the treatment of herpes virusesCOOKE ANDREW JOHN·Filed 2020·Application pending·0 cites
- 4147US7456204B2Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2004·Granted Nov 25, 2008·0 cites·22 claims
- 4246US2016229839A1Factor XIa InhibitorsMERTZ ERIC·Filed 2014·Application pending·0 cites
- 4345US8017624B2Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2006·Granted Sep 13, 2011·0 cites·17 claims
- 4445US7943615B2Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2006·Granted May 17, 2011·0 cites·8 claims
- 4545US2010113492A1Substituted Aminopyrimidines as Cholecystokinin-1 Receptor ModulatorsMERCK & CO INC·Filed 2008·Application pending·0 cites
- 4644US2018353507A1Methods of preventing or treating hypoglycemia by administering a gpr119 agonistMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 4743US8933102B2Pyrrolidine derived β3 adrenergic receptor agonistsMORRIELLO GREGORI J·Filed 2011·Granted Jan 13, 2015·0 cites·8 claims
- 4843US7858629B2Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2007·Granted Dec 28, 2010·0 cites·17 claims
- 4943US7759352B2Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2007·Granted Jul 20, 2010·0 cites·16 claims
- 5043US2015274664A1Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatmentACTON JOHN J·Filed 2013·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →